Reglagene Guest on Tucson Metro Podcast

Reglagene President & CEO Dr. Richard Austin joined the Tucson Metro Chamber podcast titled “The Business of” to explain how the company is developing revolutionary therapy for brain cancer based on research stemming from the University of Arizona that has proven a way to break through the blood-brain barrier. Reglagene is a biotech company firm that fights cancer by leveraging Quadruplex Master Switch Technology to create new medicines that regulate gene expression. Reglagene licensed the technology through Tech Launch Arizona and is part of the growing list of UACI startups.

Enjoy the podcast here.